Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 11:28 PM
Study NCT ID:
NCT00429793
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2007-01-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-30
First Submit QC Date:
None
Study First Post Date:
2007-02-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-07-09
Results First Submit QC Date:
None
Results First Post Date:
2013-11-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-22
Last Update Post Date:
2019-07-24
Last Update Post Date Type:
ACTUAL